The Technical Analyst
NEXGEL, Inc. [NXGL]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
NEXGEL, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-5.55% $2.21
America/New_York / 24 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 13.76 mill |
| EPS: | -0.560 |
| P/E: | -3.95 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 6.23 mill |
| Avg Daily Volume: | 0.0224 mill |
| RATING 2024-04-24 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.95 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.12x |
| Company: PE -3.95 | industry: PE 33.06 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.954 - 2.47 ( +/- 11.58%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-01 | Henry Scott Robert | Buy | 23 697 | Common Stock |
| 2024-03-01 | Henry Scott Robert | Buy | 11 848 | Warrant to Purchase Common Stock |
| 2024-03-01 | Glassman Steven Mark | Buy | 11 848 | Common Stock |
| 2024-03-01 | Glassman Steven Mark | Buy | 5 924 | Warrant to Purchase Common Stock |
| 2024-03-01 | Drapczuk Adam E Iii | Buy | 47 394 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 80 transactions |
| Buy: 20 316 659 | Sell: 1 500 000 |
Forecast:
14:34 - $2.32
Live Trading Signals (every 1 min)
Forecast
1: 13:04 - $2.29
Forecast 2: 13:54 - $2.32
Forecast 3: 14:34 - $2.32
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $2.21 (-5.55% ) |
| Volume | 0.0059 mill |
| Avg. Vol. | 0.0224 mill |
| % of Avg. Vol | 26.48 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NXGL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Latest Press Releases
2024-04-01 07:50:00 - Press Release
Nexgel Reports Full Year 2023 Revenue Of $4.1 Million, An Increase Of 99.7% Year-over-year
Langhorne, pa., april 01, 2024 (globe newswire) -- nexgel, inc. (“nexgel” or the “company”) (nasdaq: “nxgl”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its financial results for the fourth quarter and full year ended december 31, 2023.
2024-03-27 09:00:00 - Press Release
Nexgel Reschedules Fourth Quarter And Full Year 2023 Financial Results Conference Call To Monday, April 1st At 8:30 A.m. Et Due To Holiday
Langhorne, pa., march 27, 2024 (globe newswire) -- nexgel, inc. (“nexgel” or the “company”) (nasdaq: “nxgl”), a leading provider of medical and over-the-counter (otc) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced rescheduling its financial results conference call for the fourth quarter and full year 2023 to monday, april 1st at 8:30 a.m. et. the company intends to file its form 10-k with the sec and issue a press release prior to the start of the call.
2024-03-21 09:00:00 - Press Release
Nexgel To Report Fourth Quarter And Full Year 2023 Financial Results On March 28th
Management will host a conference call at 4:30 p.m. et on the same day langhorne, pa.
2024-03-04 08:30:00 - Press Release
Nexgel To Present At The Iaccess Alpha Best Ideas Spring Virtual Conference On March 12th
Langhorne, pa., march 04, 2024 (globe newswire) -- nexgel, inc. (“nexgel” or the “company”) (nasdaq: “nxgl”), a leading provider of medical and over-the-counter (otc) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that adam levy, chief executive officer, is scheduled to present at the iaccess alpha best ideas spring virtual conference taking place march 12th and 13th.
2024-01-09 08:30:00 - Press Release
Nexgel Subsidiary, Cg Converting And Packaging, Begins 12,000 Square Foot Expansion Of Texas Facility To Support The Expected Growth In Product Demand In 2024
Langhorne, pa., jan. 09, 2024 (globe newswire) -- nexgel, inc. (“nexgel” or the “company”) (nasdaq: nxgl), a leading provider of medical and over-the-counter (otc) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced a 12,000 square foot expansion of its cg converting and packaging facility in granbury, texas. the expansion will support the expected growth in product demand from its new strategic partnerships as well as continued growth of nexgel's own branded products.
Latest News
2024-04-01 14:25:25 - Seeking Alpha
NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript
2024-03-27 09:00:00 - GlobeNewsWire
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced rescheduling its financial results conference call for the fourth quarter and full year 2023 to Monday, April 1st at 8:30 a.m. ET. The Company intends to file its Form 10-K with the SEC and issue a press release prior to the start of the call.
2024-03-21 09:00:00 - GlobeNewsWire
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
2024-03-04 08:30:00 - GlobeNewsWire
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, is scheduled to present at the iAccess Alpha Best Ideas Spring Virtual Conference taking place March 12th and 13th.
2023-11-17 14:27:02 - Seeking Alpha
NEXGEL, Inc. (NXGL) Q3 2023 Earnings Call Transcript
NEXGEL, Inc. (NASDAQ:NXGL ) Q3 2023 Results Conference Call November 13, 2023 4:30 PM ET Company Participants Valter Pinto - MD, KCSA Strategic Communications Adam Levy - CEO Adam Drapczuk - CFO Conference Call Participants Naz Rahman - Maxim Group Operator Good afternoon. I will be your conference operator today.
2023-11-16 06:35:06 - InvestorPlace
3 Stocks You'll Regret Not Buying Soon: November 2023
The recent surge in official interest rates, the most substantial in 40 years, is anticipated to impact aggregate demand significantly. This could potentially result in a GDP reduction of approximately 4 percent for the current year, followed by an additional 1% decrease in 2024.
2023-10-30 08:51:07 - Proactive Investors
NEXGEL announces supply agreement with AbbVie
NEXGEL (NASDAQ:NXGL) announced that its CG Converting and Packaging subsidiary has executed a supply agreement with biopharmaceutical giant AbbVie Inc to be a supplier of gel pads to be used with AbbVie's Rapid Acoustic Pulse device being investigated for improvement in the appearance of cellulite. The provider of high-water-content hydrogel products said by leveraging its proprietary hydrogel technology, the gel pads will be an important component of the body contouring device.
2023-08-14 17:16:51 - Proactive Investors
Nexgel posts record 2Q revenue on contract manufacturing surge
Nexgel Inc has announced its financial results, revealing record second-quarter revenue. “Record second-quarter revenue of $1.17 million, an increase of 108% year-over-year, exceeded our projections,” CEO Adam Levy said in a statement.
2023-08-02 09:00:00 - GlobeNewsWire
NEXGEL to Report Second Quarter 2023 Financial Results on August 14th
2023-07-19 10:02:53 - Proactive Investors
NEXGEL announces retail distribution partnership with Enigma Health
NEXGEL (NASDAQ:NXGL) has announced a partnership with Engima Health for marketing services and to distribute its hydrogel products in retail stores across North America. A new joint venture (JV) company, Enigma Health will also be providing services for Moiety, a topical lotions and cream manufacturer, NEXGEL (NASDAQ:NXGL) said.